• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Lyme Disease Bacterium Triggers Lasting Epigenetic Changes in Mouse Bone Marrow

by
November 20, 2026
in Health
Reading Time: 3 mins read
0
Lyme Disease Bacterium Triggers Lasting Epigenetic Changes in Mouse Bone Marrow

Lyme Disease Bacterium Triggers Lasting Epigenetic Changes in Mouse Bone Marrow

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Infection with Borrelia burgdorferi, the bacterium responsible for Lyme disease, can cause lasting alterations in bone marrow cells even after antibiotic treatment, according to a mouse-model study led by researchers at Tufts University School of Medicine and published in the journal iScience. Bone marrow serves as the primary tissue where many of the body’s immune cells are produced, and these persistent post-infection alterations potentially modify how the immune system responds to future threats. The peer-reviewed findings provide new clues into how a bacterial infection can exert continuing biological effects after the microbes are cleared, offering insights that could eventually help scientists identify biological markers associated with prolonged illness and pinpoint potential treatment targets.

To investigate the long-term effects of Lyme disease, the research team utilized a mouse model to analyze bone marrow cells following bacterial infection, evaluating both untreated mice and animals that subsequently received antibiotics. The investigators discovered that exposure to Borrelia burgdorferi produced distinct epigenetic changes—chemical modifications that directly influence which specific genes are turned on or off—in bone marrow cells. Senior author Tanja Petnicki-Ocwieja, a research assistant professor of molecular biology and microbiology at Tufts University School of Medicine, explained that a lifetime of infections and inflammatory exposures creates editing marks in the immune system’s historical record of prior encounters. Petnicki-Ocwieja noted that these epigenetic changes imprinted within the bone marrow may essentially revise the immune system’s biography and govern how it responds over time.

These cellular modifications were especially pronounced in macrophages, specialized immune cells generated in the bone marrow that act as early responders during an infection. Under standard conditions, macrophages detect foreign threats, engulf invading microbes, and release chemical signals designed to summon other immune cells to destroy invaders. However, macrophages produced by mice previously exposed to Borrelia burgdorferi exhibited suppressed expression of genes involved in driving this inflammatory defense. This suppression of inflammatory gene expression persisted for at least 15 weeks following the initial infection. As Petnicki-Ocwieja described, while macrophages sound alarm bells to summon other immune cells upon first encountering the bacteria, subsequent epigenetic imprinting in the bone marrow causes them to sound fewer alarms.

Significantly, this altered immune response was also detected in experimental mice that received antibiotic treatment following infection. The observation that treated animals still displayed altered macrophage responses indicates that these epigenetic shifts occur relatively early during the course of infection and do not require prolonged or ongoing active bacterial illness. First author Yuelin Zhong, a PhD student in immunology at the Tufts Graduate School of Biomedical Sciences, emphasized that an individual’s initial exposure to Borrelia burgdorferi appears sufficient to cause long-term consequences for the immune response.

Despite the findings observed in the animal model, the authors underscored that the study does not establish that identical immune alterations occur in human patients with Lyme disease or that such mechanisms cause persistent symptoms. To determine whether these epigenetic modifications are relevant to human illness, the investigators plan to examine epigenetic markers in human clinical cohorts following Lyme disease infection. Petnicki-Ocwieja will collaborate with study co-author Linden Hu, the Paul and Elaine Chervinsky Professor of Immunology at the School of Medicine, to analyze circulating immune cells obtained from blood samples in a large, Tufts-led multi-institution clinical study that monitors patients for up to 15 months after receiving a Lyme disease diagnosis.

Through this human patient research, the investigators hope to determine whether individuals who develop prolonged symptoms exhibit different epigenetic signatures compared to individuals who recover without lasting symptoms. Petnicki-Ocwieja stated that the ultimate goal is to sequence these epigenetic marks to establish comprehensive profiles of how Lyme disease influences an individual’s immune system, allowing comparisons between patients experiencing long-term symptoms and those who have fully recovered. If distinct epigenetic profiles are identified, they could yield vital explanations for why certain patients experience lingering post-treatment manifestations—such as persistent fatigue, joint pain, or cognitive difficulties—while helping researchers establish objective biomarkers for prolonged illness and develop new therapeutic approaches.

The study received financial support from the Global Lyme Alliance, a Tufts Graduate School of Biomedical Sciences Dean’s Fellow Award, and several awards from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases. Regarding study disclosures, co-author Linden Hu receives support for contract research services through Tufts University from companies including Moderna, Sanofi, Tarsus, and Massbiologics for unrelated vaccine and drug development projects, while the authors noted that the content remains solely their responsibility and does not necessarily represent the official views of their funding organizations.

Subject of Research: Epigenetic reprogramming of bone marrow cells caused by Borrelia burgdorferi infection

Article Title: Lyme disease rewrites the body’s immune response

Article References: Lyme disease rewrites the body’s immune response. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: Borrelia burgdorferi, Lyme disease, bone marrow, epigenetic changes, macrophages, immune response, antibiotic treatment, gene expression, inflammatory response, Tufts University School of Medicine, Tanja Petnicki-Ocwieja, Yuelin Zhong, Linden Hu, iScience, mouse model, biomarkers, persistent symptoms, immune cells

News Source: Juliet Wilcox. (November 20, 2026). Lyme Disease Bacterium Triggers Lasting Epigenetic Changes in Mouse Bone Marrow. Scienmag.

Tags: antibiotic treatmentbiomarkersbone marrowBorrelia burgdorferiepigenetic changesgene expressionimmune cellsimmune responseinflammatory responseiScienceLinden HuLyme diseasemacrophagesmouse modelpersistent symptomsTanja Petnicki-OcwiejaTufts University School of MedicineYuelin Zhong
Share12Tweet7Share2ShareShareShare1

Related Posts

Older Age Linked to Lower Salivary Viscosity and MUC7 Concentrations

Older Age Linked to Lower Salivary Viscosity and MUC7 Concentrations

November 20, 2026
Survey Finds High Generative AI Adoption but Rare Formal Training in Medical College

Survey Finds High Generative AI Adoption but Rare Formal Training in Medical College

November 20, 2026

Oncology Staff Essays Reveal Mutual Psychological Benefits in Long-Term Cancer Care

November 20, 2026

Targeting Folate Receptor Overcomes Immunotherapy Resistance in Colorectal Cancer in Mice

November 20, 2026

POPULAR NEWS

  • Targeting Folate Receptor Overcomes Immunotherapy Resistance in Colorectal Cancer in Mice

    Targeting Folate Receptor Overcomes Immunotherapy Resistance in Colorectal Cancer in Mice

    29 shares
    Share 12 Tweet 7
  • Jiangxi Cities Narrowed Gaps in Healthcare Workforce and Beds Over Ten Years

    29 shares
    Share 12 Tweet 7
  • Dimethoate Metabolites Pose Greater Predicted Toxicological Risks Than Parent Insecticide

    29 shares
    Share 12 Tweet 7
  • Dual-Frequency Electroacupuncture Modulates Neurotransmitters and Relieves Insomnia in Mice

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Older Age Linked to Lower Salivary Viscosity and MUC7 Concentrations

Survey Finds High Generative AI Adoption but Rare Formal Training in Medical College

Cranial Suture Stem Cells and Artificial Intelligence Point Toward Biological Craniosynostosis Therapies

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.